View in EDS HTML Full Text PDF Full Text

A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.

Saved in:
Bibliographic Details
Title: A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.
Authors: Wang S; Vaxxinity, Inc., Dallas, TX, USA., Wang CY; United Biomedical Inc., Asia, Taipei, Taiwan.; United BioPharma, HuKo, Taiwan., Kuo HK; United Biomedical Inc., Asia, Taipei, Taiwan., Peng WJ; United Biomedical Inc., Asia, Taipei, Taiwan., Huang JH; United Biomedical Inc., Asia, Taipei, Taiwan., Kuo BS; United BioPharma, HuKo, Taiwan., Lin F; United Biomedical Inc., Hauppauge, NY, USA., Liu YJ; United BioPharma, HuKo, Taiwan., Liu Z; United Biomedical Inc., Hauppauge, NY, USA., Wu HT; United Biomedical Inc., Asia, Taipei, Taiwan., Ding S; United Biomedical Inc., Hauppauge, NY, USA., Hou KL; United Biomedical Inc., Asia, Taipei, Taiwan., Cheng J; United Biomedical Inc., Asia, Taipei, Taiwan., Yang YT; United Biomedical Inc., Asia, Taipei, Taiwan., Jiang MH; United Biomedical Inc., Asia, Taipei, Taiwan., Wang MS; United Biomedical Inc., Asia, Taipei, Taiwan., Chen T; United Biomedical Inc., Asia, Taipei, Taiwan., Xia WG; United Biomedical Inc., Hauppauge, NY, USA., Lin E; United Biomedical Inc., Hauppauge, NY, USA., Hung CH; United Biomedical Inc., Hauppauge, NY, USA., Chen HJ; United BioPharma, HuKo, Taiwan., Shih Z; United BioPharma, HuKo, Taiwan., Lin YL; Emerging Infectious Disease Division, Academia Sinica, Nangang, Taiwan., Ryan V; Vaxxinity, Inc., Dallas, TX, USA., Hu MM; Vaxxinity, Inc., Dallas, TX, USA.; United Biomedical Inc., Hauppauge, NY, USA., Heppner DG; Vaxxinity, Inc., Dallas, TX, USA., Malherbe DC; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Galveston National Laboratory, Galveston, TX, USA., Periasamy S; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Galveston National Laboratory, Galveston, TX, USA., Kuzmina N; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Galveston National Laboratory, Galveston, TX, USA., Subramani C; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Galveston National Laboratory, Galveston, TX, USA., Hellerstein M; Vaxxinity, Inc., Dallas, TX, USA., Monath TP; Vaxxinity, Inc., Dallas, TX, USA., Rumyantsev A; Vaxxinity, Inc., Dallas, TX, USA., Bukreyev A; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA.; Galveston National Laboratory, Galveston, TX, USA., Guirakhoo F; Vaxxinity, Inc., Dallas, TX, USA.
Source: Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 2724-2734.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN: 2222-1751 (Electronic) Linking ISSN: 22221751 NLM ISO Abbreviation: Emerg Microbes Infect Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2222-1751
DOI:10.1080/22221751.2022.2140608